(Q34303865)

1 August 2017

1 reference

title

Evaluation of risks associated with short- and long-term psychostimulant therapy for treatment of ADHD in children. (English)

1 reference

1 August 2017

3

Robert L Findling

1 reference

1 August 2017

Todd Kociancic

1

1 reference

PubMed ID

15006715

1 August 2017

Michael D Reed

series ordinal

2

1 reference

PubMed ID

15006715

1 August 2017

language of work or name

English

0 references

publication date

1 March 2004

1 reference

Expert Opinion on Drug Safety

1 August 2017

1 reference

1 August 2017

3

1 reference

1 August 2017

2

1 reference

1 August 2017

93-100

1 reference

Prevalence of medication treatment for attention deficit-hyperactivity disorder among elementary school children in Johnston County, North Carolina.

1 August 2017

1 reference

https://api.crossref.org/works/10.1517%2F14740338.3.2.93

Does the treatment of attention-deficit/hyperactivity disorder with stimulants contribute to drug use/abuse? A 13-year prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.3.2.93

Randomized, controlled trial of oros methylphenidate once a day in children with attention-deficit/hyperactivity disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.3.2.93

Developmental aspects of psychostimulant treatment in children and adolescents with attention-deficit/hyperactivity disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.3.2.93

A double-blind, placebo-controlled study of modified-release methylphenidate in children with attention-deficit/hyperactivity disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.3.2.93

The use of psychostimulants in the pediatric patient.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.3.2.93

Hyperactive boys almost grown up. III. Methylphenidate effects on ultimate height

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.3.2.93

Side effects of methylphenidate and dexamphetamine in children with attention deficit hyperactivity disorder: a double-blind, crossover trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.3.2.93

Treatment of ADHD in children with tics: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.3.2.93

Understanding and preventing substance abuse by adolescents: a guide for primary care clinicians.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.3.2.93

Pharmacotherapy of attention-deficit/hyperactivity disorder reduces risk for substance use disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.3.2.93

Does stimulant treatment place children at risk for adult substance abuse? A controlled, prospective follow-up study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.3.2.93

Does stimulant therapy of attention-deficit/hyperactivity disorder beget later substance abuse? A meta-analytic review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.3.2.93

Short-term cardiovascular effects of methylphenidate and adderall

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.3.2.93

Double-blind, placebo-controlled study of single-dose amphetamine formulations in ADHD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.3.2.93

Pemoline hepatotoxicity in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.3.2.93

Pemoline-associated fulminant liver failure: testing the evidence for causation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.3.2.93

Attention deficit/hyperactivity disorder and methylphenidate. A review of height/weight, cardiovascular, and somatic complaint side effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.3.2.93

Attention deficit/hyperactivity disorder across the lifespan

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.3.2.93

One-year follow-up of hyperactive boys treated with imipramine or methylphenidate

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.3.2.93

Growth deficits in ADHD children revisited: evidence for disorder-associated growth delays?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.3.2.93

ADHD treatment with once-daily OROS methylphenidate: interim 12-month results from a long-term open-label study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.3.2.93

21 January 2018

Identifiers

DOI

10.1517/14740338.3.2.93

1 reference

1 August 2017

1 reference

PubMed ID

15006715